Tomo Drug Testing names new president

Tomo Drug Testing promoted from within for its new president.

Angela Garrison, the drug-testing company’s vice president of operations since she was hired in 2017, took on her new role Aug. 1, according to a news release sent this morning to Springfield Business Journal. She succeeds five-year President Alex Haldiman, who remained with the firm but shifted into developing and expanding internal software systems.

“We strongly believe our best chance to succeed as a company is to always be evaluating if we each serve in roles that suit our unique strengths and talents,” Haldiman said in the release. “Angela has the ability to lead Tomo to new heights through her natural abilities, and I'll focus on our internal software systems which are also very important in our growth.”

A member of SBJ’s 2019 class of 40 Under 40, Haldiman is credited with leading growth of more than 300% over the past three years, as well as the development of software that manages services for over 2,000 clients and 5,000 tests per week, according to the release. Tomo Drug Testing in 2018 made the annual fast-growth Inc. 5000 list, with 2017 revenue of $8.5 million representing a three-year increase of 238%.

Garrison came to Tomo Drug Testing from Safe and Sober, where she worked two years as development director, according to her LinkedIn page. At Tomo, she reports to CEO Mickey Moore.

“These are truly exciting times that bring with them exciting opportunities: from updating testing and systems and successfully integrating newly acquired clients to leveling up companywide planning, processes and communications,” Garrison said in the release.